AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2014
Apr 3, 2014
31580_dirs_2014-04-03_4dc42a61-322c-435b-8ea2-d304a086cb8b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2014-04-01
Reporting Person: Biller Scott (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-01 | Common stock | M | 18000 | $0.4675 | Acquired | 18000 | Direct |
| 2014-04-01 | Common stock | M | 12000 | $0.4675 | Acquired | 30000 | Direct |
| 2014-04-01 | Common stock | M | 4500 | $0.4675 | Acquired | 34500 | Direct |
| 2014-04-01 | Common stock | S | 4500 | $38.08 | Disposed | 30000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-01 | Stock option (right to buy) | $0.4675 | M | 18000 | Disposed | 2020-12-06 | Common stock (18000) | Direct |
| 2014-04-01 | Stock option (right to buy) | $0.4675 | M | 12000 | Disposed | 2020-12-06 | Common stock (12000) | Direct |
| 2014-04-01 | Stock option (right to buy) | $0.4675 | M | 4500 | Disposed | 2020-12-06 | Common Stock (4500) | Direct |
Footnotes
F1: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $36.58 to $39.57. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: This option was granted on December 7, 2010. The shares underlying this option vest as to 25% of the shares on September 20, 2011, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F5: This option was granted on December 7, 2010. The shares underlying this option vested as to 25% of the shares upon the achievement of a performance milestone on March 18, 2013. The remaining 75% of the shares underlying the option vest in equal monthly installments through March 18, 2016.